05/01/2024
6:32 PM | Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2024
6:36 PM | Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:30 PM | Akero Therapeutics (Filer)
| Form PRE 14A | |
04/03/2024
5:55 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:17 PM | Akero Therapeutics (Subject)
Young Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
3:31 PM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:42 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/15/2024
3:42 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:43 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:44 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:45 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
9:08 AM | Akero Therapeutics (Subject)
GENERAL ATLANTIC, L.P. (Filed by)
| Form SC 13G | |
03/06/2024
7:13 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:14 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:25 PM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:16 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
03/05/2024
4:16 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:30 PM | Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
6:55 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:42 PM | Akero Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024
6:30 AM | Akero Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
6:15 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:19 PM | Akero Therapeutics (Subject)
PFIZER INC (Filed by)
| Form SC 13G/A | |
02/14/2024
6:06 AM | Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/13/2024
8:40 PM | Akero Therapeutics (Subject)
Avidity Partners Management LP (Filed by)
| Form SC 13G/A | |
02/13/2024
5:30 PM | Akero Therapeutics (Subject)
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
10:31 AM | Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/07/2024
6:23 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Akero Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024
8:36 AM | Akero Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/29/2023
7:30 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
5:07 PM | Akero Therapeutics (Subject)
Young Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
7:49 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:37 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:39 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:40 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:29 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
6:08 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
3:43 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:43 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:35 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:38 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The AI Stock that’s Disrupting Every Industry (Ad) Move over Nvidia. There’s a new hot AI play that has soared 960% in the past year.
One high-flying artificial intelligence stock has soared 960% over the past year and may soon become as familiar as Nvidia… Here's the Ticker >>> |
12/12/2023
3:26 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
7:59 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
8:06 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
7:37 AM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:30 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:37 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
6:33 AM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
6:15 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
7:04 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
7:33 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
7:41 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
5:17 PM | Akero Therapeutics (Subject)
Young Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023
5:21 PM | Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2023
7:28 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
7:30 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
7:31 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
7:31 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
7:36 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
5:48 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
6:04 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
6:04 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
8:02 PM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023
5:09 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
3:13 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
6:52 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
7:44 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
12:07 PM | Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2023
6:12 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
5:00 PM | Akero Therapeutics (Issuer)
Xu Yuan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:52 PM | Akero Therapeutics (Issuer)
Heyman Tomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:55 PM | Akero Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:58 PM | Akero Therapeutics (Issuer)
Judy Chou (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:39 PM | Akero Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:48 PM | Akero Therapeutics (Issuer)
Harrison Seth Loring (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:48 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:29 PM | Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023
3:02 PM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
7:06 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:20 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:54 PM | Akero Therapeutics (Issuer)
Heyman Tomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:46 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:47 PM | Akero Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
5:00 PM | Akero Therapeutics (Subject)
Heyman Tomas J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
4:41 PM | Akero Therapeutics (Subject)
Henderson Jane (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:22 PM | Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
8:38 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
8:41 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
8:29 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
8:35 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
8:35 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Long-Awaited End of America Update (Ad) A 995% Gain Last Time We Shared this "Election Secret"
It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it. Click here to find out for free. |
06/15/2023
8:26 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4/A | |
06/05/2023
5:23 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
7:05 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
8:55 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023
6:19 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
7:28 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
